IP48-16: Risk of Urinary Tract Infections, Pyelonephritis, and Sepsis in Patients with Type 2 Diabetes Mellitus on SGLT2 Inhibitors: A Real-World Multicenter Cohort Study

IP48-16: Risk of Urinary Tract Infections, Pyelonephritis, and Sepsis in Patients with Type 2 Diabetes Mellitus on SGLT2 Inhibitors: A Real-World Multicenter Cohort Study

Saturday, May 16, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)
147B
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!